Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase

被引:15
作者
Isaguliants, MG
Pokrovskaya, K
Kashuba, VI
Pokholok, D
Hinkula, J
Wahren, B
Kochetkov, SN
机构
[1] DI Ivanovskii Virol Inst, Moscow 123098, Russia
[2] Swedish Inst Infect Dis Control, SMI, Karolinska Inst, S-17182 Stockholm, Sweden
[3] Karolinska Inst, MTC, Mol & Tumourbiol Ctr, S-17177 Stockholm, Sweden
[4] Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine
[5] WA Engelgardt Inst Mol Biol, Moscow 117984, Russia
关键词
human immunodeficiency virus type 1; reverse transcriptase; eukaryotic expression; DNA immunization;
D O I
10.1016/S0014-5793(99)00297-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reverse transcriptase of human immunodeficiency virus type 1 is a vitalenzyme in the HIV-1 replication cycle and an attractive target of attempts to arrest a primary viral infection. We designed a vector for eukaryotic expression of the 66 kDa subunit of reverse transcriptase under the control of the immediate early cytomegalovirus promoter, Efficient transient expression of the 66 kDa subunit of reverse transcriptase was achieved in a variety of cells. Immunostaining of the transfected cells revealed the cytoplasmatic localization of reverse transcriptase, Reverse transcriptase activity was detected in all transfected cell lines. Injection of this plasmid encoding the 66 kDa subunit of reverse transcriptase into mice resulted in strong reverse transcriptase-specific immune responses indicating that the 66 kDa subunit of reverse transcriptase is expressed in vivo. Sera from DNA-immunized mice inhibited reverse transcription in vitro. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:232 / 236
页数:5
相关论文
共 20 条
[1]  
DAVIS HL, 1995, MOL CELL BIOL HUMAN, P368
[2]  
DEIBEL MR, 1990, AIDS RES HUM RETROV, P329
[3]  
GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817
[4]   Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes [J].
Hinkula, J ;
Svanholm, C ;
Schwartz, S ;
Lundholm, P ;
Brytting, M ;
Engstrom, G ;
Benthin, R ;
Glaser, H ;
Sutter, G ;
Kohleisen, B ;
Erfle, V ;
Okuda, K ;
Wigzell, H ;
Wahren, B .
JOURNAL OF VIROLOGY, 1997, 71 (07) :5528-5539
[5]   IMMUNOGENIC COMBINATIONS OF HIV-1 B-EPITOPES AND HETEROLOGOUS T-CELL-EPITOPES [J].
ISAGULIANTS, M ;
RUDEN, U ;
GILLJAM, G ;
WAHREN, B .
IMMUNOLOGY LETTERS, 1994, 42 (03) :173-178
[6]  
ISAGULIANTS M, 1997, 2 EUR C EXP AIDS RES
[7]   CHARACTERIZATION AND CLINICAL-ASSOCIATION OF ANTIBODY INHIBITORY TO HIV REVERSE-TRANSCRIPTASE ACTIVITY [J].
LAURENCE, J ;
SAUNDERS, A ;
KULKOSKY, J .
SCIENCE, 1987, 235 (4795) :1501-1504
[8]   A method for combined immunoaffinity purification and assay of HIV-1 reverse transcriptase activity useful for crude samples [J].
Lennerstrand, J ;
Rytting, AS ;
Orvell, C ;
Gronowitz, JS ;
Kallander, CFR .
ANALYTICAL BIOCHEMISTRY, 1996, 235 (02) :141-152
[9]   INTRACELLULAR NEUTRALIZATION OF VIRUS BY IMMUNOGLOBULIN-A ANTIBODIES [J].
MAZANEC, MB ;
KAETZEL, CS ;
LAMM, ME ;
FLETCHER, D ;
NEDRUD, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :6901-6905
[10]   IMMUNOLOGICAL CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE PROTEIN BY THE USE OF MONOCLONAL-ANTIBODIES [J].
ORVELL, C ;
UNGE, T ;
BHIKHABHAI, R ;
BACKBRO, K ;
RUDEN, U ;
STRANDBERG, B ;
WAHREN, B ;
FENYO, EM .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :1913-1918